Status:
COMPLETED
Salivary Cortisol as Stress Marker in Newborns Subjected to Double Weighing With Physiological Body Weight
Lead Sponsor:
Fondazione Poliambulanza Istituto Ospedaliero
Conditions:
Cortisol Overproduction
Eligibility:
All Genders
37-42 years
Brief Summary
According to scientific revisions, salivary cortisol is a valid method for measuring adrenocortical activity in newborns because it is non-invasive in fact the measurement of salivary cortisol has bee...
Detailed Description
After the phase of early adaptation, newborn must learn quickly to live out of the mother uterus. In this phase of life, physiological mechanisms are activated. Newborn loss body weight because loss l...
Eligibility Criteria
Inclusion
- Gestational age: 37-42 wks
- Body Weight: \>2500 g
- Body weight loss \>3±1,5% at 24 hr from birth
- First-born
- Eutocic delivery
- Mother BMI:19-24
- Glycaemia \>50 mg/dl
Exclusion
- Mother disease
- Admission in NICU
- Neonatal pathologies
- Utilization of human milk
- Body weight loss \> 10%
Key Trial Info
Start Date :
September 21 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03830437
Start Date
September 21 2018
End Date
June 1 2019
Last Update
July 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Poliambulanza Istituto Ospedaliero
Brescia, Italy, 25121